Oryzon Genomics SA Strategic Asset Allocation Index
Oryzon Genomics SA strategic asset allocation index. Oryzon Genomics SA (ORY) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of €545.97K plus long-term investments of €-) total €545.97K, measured against net assets of €78.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ORY net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Oryzon Genomics SA (2011–2022)
Strategic asset allocation index of Oryzon Genomics SA from 2011 to 2022. This chart shows how Oryzon Genomics SA's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 0.7%, representing strategic assets of €545.97K against net assets of €78.54 Million EUR. Check Oryzon Genomics SA (ORY) tangible net worth to evaluate the tangible quality of the company's equity base.
Oryzon Genomics SA Strategic Asset Allocation Index by Year (2011–2022)
Oryzon Genomics SA strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Oryzon Genomics SA from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Oryzon Genomics SA stock valuation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.8% | €611.42K | €611.42K | €- | €72.57 Million | ▼ -0.1 pp |
| 2021 | 1.0% | €682.42K | €682.42K | €- | €71.26 Million | ▲ +0.1 pp |
| 2020 | 0.8% | €643.92K | €643.92K | €- | €75.93 Million | ▲ +0.0 pp |
| 2019 | 0.8% | €672.08K | €631.28K | €40.80K | €80.02 Million | ▼ -0.7 pp |
| 2018 | 1.6% | €705.71K | €664.91K | €40.80K | €45.13 Million | ▼ -0.4 pp |
| 2017 | 2.0% | €679.28K | €638.28K | €41.00K | €34.43 Million | ▼ -1.3 pp |
| 2016 | 3.2% | €736.87K | €695.87K | €41.00K | €22.73 Million | ▼ -1.1 pp |
| 2015 | 4.3% | €1.20 Million | €853.56K | €344.29K | €27.59 Million | ▼ -6.4 pp |
| 2014 | 10.7% | €1.49 Million | €981.00K | €505.57K | €13.89 Million | ▼ -2.9 pp |
| 2013 | 13.6% | €2.00 Million | €1.16 Million | €844.78K | €14.73 Million | ▲ +4.6 pp |
| 2012 | 9.0% | €1.49 Million | €1.49 Million | €- | €16.43 Million | ▼ -1.2 pp |
| 2011 | 10.2% | €1.71 Million | €1.71 Million | €- | €16.76 Million | — |